Entrada Therapeutics Inc. (TRDA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Entrada Therapeutics Inc.

    NASDAQ: TRDA · Real-Time Price · USD
    5.95
    0.03 (0.51%)
    At close: Oct 03, 2025, 3:19 PM

    Entrada Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 101.21M 67.6M 45.16M 291.06M
    Short-Term Investments
    		 318.79M 284.37M 143.56M n/a
    Long-Term Investments
    		 n/a n/a 3.95M n/a
    Other Long-Term Assets
    		 4.23M 6.74M 5.21M 872K
    Receivables
    		 3.68M 5.88M n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 16.36M 11.92M 21.16M n/a
    Total Current Assets
    		 440.04M 369.77M 209.88M 298.7M
    Property-Plant & Equipment
    		 82.05M 92.68M 33.02M 6.26M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 86.28M 99.42M 42.18M 7.13M
    Total Assets
    		 526.32M 469.19M 252.06M 305.83M
    Account Payables
    		 4.26M 3.28M 5.99M 706K
    Deferred Revenue
    		 13.65M 132.26M n/a n/a
    Short-Term Debt
    		 n/a 7.02M 8.41M n/a
    Other Current Liabilities
    		 8.43M 11.69M -2.91M 485K
    Total Current Liabilities
    		 39.48M 158.8M 21.97M 6.72M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 6.51M n/a n/a 396K
    Total Long-Term Liabilities
    		 58.16M 68.04M 17.53M 396K
    Total Liabilities
    		 97.64M 226.83M 39.5M 7.12M
    Total Debt
    		 59.21M 68.23M 25.94M n/a
    Book Value
    		 428.68M 242.36M 212.55M 298.72M
    Book Value Per Share
    		 11.49 7.33 6.79 9.57
    Common Stock
    		 4K 3K 3K 3K
    Retained Earnings
    		 -129.34M -194.97M -188.28M -93.67M
    Comprehensive Income
    		 -43K 195K -2.06M -305.83M
    Shareholders Equity
    		 428.68M 242.36M 212.55M 298.72M
    Total Investments
    		 318.79M 284.37M 143.56M n/a

    Add to Watchlist